Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective…
Continue Reading
Table of Contents
Berg Family’s Transformative Donation
Mayo Clinic Berg Innovation Exchange Overview
Unique Philanthropy-Driven Model
Global Healthcare Innovation Strategy
Technology Focus Areas
Future Impact and Expansion Plans
Berg Family’s Transformative Donation
Rochester, Minnesota-based Mayo Clinic has received a groundbreaking $50 million…
Image Credit: b-rayZ
What You Should Know:
– Affidea, a pan-European provider of community-based polyclinics, specialist services, and advanced diagnostics, has announced a strategic collaboration with b-rayZ, a leader in AI-powered breast imaging solutions.
– The strategic…
Continue Reading
Clinicians have secure access to over 160,000 pharmacogenomics reports through Malaffi.These reports provide genetic insights that support safer, more effective, and personalized care — marking a major step forward for precision medicine in Abu…
Continue Reading
Digital twins have been used in industries and is now gaining traction in healthcare, particularly in precision medicine. Discrete Event Simulation is a modelling methodology for simulating processes and workflows in healthcare. This paper…
Continue Reading
Noah Nasser, CEO at datma
In today’s precision medicine landscape, pharmaceutical companies and access teams face a critical challenge: understanding not just whether therapies work, but how they are accessed, adopted, and experienced by real-world…
Continue Reading
Cancer research organization City of Hope has co-led a study to show that characterizing genetic material close to chromosomes predicts how mutated, cancer-causing genes reprogram DNA and alter the tumor microenvironment. City of Hope said…
Continue Reading
Seoul National University Hospital has recently unveiled a clinical decision support system for precision medicine treatment.WHY IT MATTERS
The SNUH POLARIS (Precision Oncology and Rare-Common Disease Supporter) is said to be the first of its…
What You Should Know:
– Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform…
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
